References
- Schwartz C L. Special issues in pediatric Hodgkin's disease. Eur J Haematol 2005; 75: 55–62
- van Grotel M, Lam K H, de Man R, Beishuizen A, Pieters R, van den Heuvel-Eibrink M M. High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy only. Leuk Lymphoma 2006; 47: 1504–1510
- Vassilakopoulos T P, Angelopoulou M K, Siakantaris M P, Kontopidou F N, Dimopoulou M N, Kokoris S I, et al. Combination chemotherapy plus low-dose involved field radiotherapy for early clinical stage Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 2004; 59: 765–781
- Nachman J B, Sposto R, Herzog P, Gilchrist G S, Wolden S L, Thomson J, et al. Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. J Clin Oncol 2002; 20: 3765–3771
- Klimm B, Schnell R, Diehl V, Engert A. Current treatment and immunotherapy of Hodgkin's lymphoma. Haematologica 2005; 90: 1680–1692
- Nogova L, Reineke T, Eich H T, Josting A, Muller-Hermelink H K, Wingbermuhle K, et al. Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG). Ann Oncol 2005; 16: 1683–1687
- Straus D J, Portlock C S, Qin J, Myers J, Zelenetz A D, Moskowitz C, et al. Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) followed by radiation therapy (RT) vs. ABVD alone for stages I, II and IIIA non bulky Hodgkin's disease. Blood 2004; 104: 3483–3489
- Meyer R, Gospodarowicz M K, Connors J, Pearcey R G, Bezjak A, Wells W A, et al. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group. J Clin Oncol 2005; 23: 4634–4642
- Pellegrino B, Terrier-Lacombe M J, Oberlin O, Leblanc T, Perel Y, Bertrand Y, et al. Lymphocyte-predominant Hodgkin's lymphoma in children: Therapeutic abstention after initial lymph node resection – a study of the French Society of Pediatric Oncology. J Clin Oncol 2003; 21: 2948–2952